港股異動丨寶龍商業(09909.HK)漲4.21% 再創上市以來新高
格隆匯5月14日丨寶龍商業(09909.HK)漲4.21%,報14.84港元,股價再創上市以來新高,今年累計漲幅達51%,總市值92億港元。寶龍商業將獲納入MSCI中國小型股指數成份股,於2020年5月29日收市後生效。MSCI中國小型股指數乃為計量中國市場小型股分部的表現而設。董事會確信,公司獲納入MSCI中國小型股指數,顯示資本市場對公司表現及價值的認可,預期將有利於提升公司知名度及增加股份流動性,從而實現公司的投資價值。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.